MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
43 hedge funds and large institutions have $50.5M invested in Merrimack Pharmaceuticals, Inc. in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
59% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 17
88% less call options, than puts
Call options by funds: $38K | Put options by funds: $317K
Holders
43
Holding in Top 10
1
Calls
$38K
Puts
$317K
Top Buyers
| 1 | +$1.65M | |
| 2 | +$1.34M | |
| 3 | +$226K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$220K |
| 5 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
+$86K |
Top Sellers
| 1 | -$989K | |
| 2 | -$741K | |
| 3 | -$551K | |
| 4 |
BlackRock
New York
|
-$437K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$412K |